Restricted and Repetitive Behavior and Brain Functional Connectivity in Infants at Risk for Developing Autism Spectrum Disorder.


Journal

Biological psychiatry. Cognitive neuroscience and neuroimaging
ISSN: 2451-9030
Titre abrégé: Biol Psychiatry Cogn Neurosci Neuroimaging
Pays: United States
ID NLM: 101671285

Informations de publication

Date de publication:
01 2019
Historique:
received: 02 08 2018
accepted: 01 09 2018
pubmed: 18 11 2018
medline: 7 1 2020
entrez: 18 11 2018
Statut: ppublish

Résumé

Restricted and repetitive behaviors (RRBs), detectable by 12 months in many infants in whom autism spectrum disorder (ASD) is later diagnosed, may represent some of the earliest behavioral markers of ASD. However, brain function underlying the emergence of these key behaviors remains unknown. Behavioral and resting-state functional connectivity (fc) magnetic resonance imaging data were collected from 167 children at high and low familial risk for ASD at 12 and 24 months (n = 38 at both time points). Twenty infants met criteria for ASD at 24 months. We divided RRBs into four subcategories (restricted, stereotyped, ritualistic/sameness, self-injurious) and used a data-driven approach to identify functional brain networks associated with the development of each RRB subcategory. Higher scores for ritualistic/sameness behavior were associated with less positive fc between visual and control networks at 12 and 24 months. Ritualistic/sameness and stereotyped behaviors were associated with less positive fc between visual and default mode networks at 12 months. At 24 months, stereotyped and restricted behaviors were associated with more positive fc between default mode and control networks. Additionally, at 24 months, stereotyped behavior was associated with more positive fc between dorsal attention and subcortical networks, whereas restricted behavior was associated with more positive fc between default mode and dorsal attention networks. No significant network-level associations were observed for self-injurious behavior. These observations mark the earliest known description of functional brain systems underlying RRBs, reinforce the construct validity of RRB subcategories in infants, and implicate specific neural substrates for future interventions targeting RRBs.

Sections du résumé

BACKGROUND
Restricted and repetitive behaviors (RRBs), detectable by 12 months in many infants in whom autism spectrum disorder (ASD) is later diagnosed, may represent some of the earliest behavioral markers of ASD. However, brain function underlying the emergence of these key behaviors remains unknown.
METHODS
Behavioral and resting-state functional connectivity (fc) magnetic resonance imaging data were collected from 167 children at high and low familial risk for ASD at 12 and 24 months (n = 38 at both time points). Twenty infants met criteria for ASD at 24 months. We divided RRBs into four subcategories (restricted, stereotyped, ritualistic/sameness, self-injurious) and used a data-driven approach to identify functional brain networks associated with the development of each RRB subcategory.
RESULTS
Higher scores for ritualistic/sameness behavior were associated with less positive fc between visual and control networks at 12 and 24 months. Ritualistic/sameness and stereotyped behaviors were associated with less positive fc between visual and default mode networks at 12 months. At 24 months, stereotyped and restricted behaviors were associated with more positive fc between default mode and control networks. Additionally, at 24 months, stereotyped behavior was associated with more positive fc between dorsal attention and subcortical networks, whereas restricted behavior was associated with more positive fc between default mode and dorsal attention networks. No significant network-level associations were observed for self-injurious behavior.
CONCLUSIONS
These observations mark the earliest known description of functional brain systems underlying RRBs, reinforce the construct validity of RRB subcategories in infants, and implicate specific neural substrates for future interventions targeting RRBs.

Identifiants

pubmed: 30446435
pii: S2451-9022(18)30247-7
doi: 10.1016/j.bpsc.2018.09.008
pmc: PMC6557405
mid: NIHMS1512245
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

50-61

Subventions

Organisme : NICHD NIH HHS
ID : U54 HD087011
Pays : United States
Organisme : NICHD NIH HHS
ID : U54 HD079124
Pays : United States
Organisme : NICHD NIH HHS
ID : U54 HD086984
Pays : United States
Organisme : NICHD NIH HHS
ID : R01 HD055741
Pays : United States
Organisme : NIEHS NIH HHS
ID : P30 ES010126
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH093510
Pays : United States
Organisme : NIMH NIH HHS
ID : K01 MH103594
Pays : United States
Organisme : NIMH NIH HHS
ID : K01 MH101653
Pays : United States

Informations de copyright

Copyright © 2018 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.

Références

J Am Acad Child Adolesc Psychiatry. 2014 Nov;53(11):1216-24
pubmed: 25440311
Hum Brain Mapp. 2012 Jan;33(1):192-202
pubmed: 21391263
Proc Natl Acad Sci U S A. 2006 May 23;103(21):8239-44
pubmed: 16702554
Nat Neurosci. 2017 Dec;20(12):1744-1751
pubmed: 29184200
Neuroimage. 2013 Aug 1;76:183-201
pubmed: 23499792
Sci Rep. 2014 Mar 07;4:4301
pubmed: 24603348
Cereb Cortex. 2017 Mar 1;27(3):1709-1720
pubmed: 28062515
J Autism Dev Disord. 2009 Apr;39(4):635-42
pubmed: 19015969
J Neurosci. 2004 Oct 20;24(42):9228-31
pubmed: 15496656
Psychol Med. 2009 Sep;39(9):1559-66
pubmed: 19154646
Res Autism Spectr Disord. 2009 Oct;3(4):959-966
pubmed: 21475640
J Neurosci. 2014 Jan 8;34(2):451-61
pubmed: 24403145
J Child Psychol Psychiatry. 2006 Jun;47(6):573-81
pubmed: 16712634
BMC Genomics. 2014 Jul 22;15:622
pubmed: 25052024
Neuroimage. 2017 Jul 1;154:174-187
pubmed: 28302591
Arch Gen Psychiatry. 2008 Aug;65(8):946-54
pubmed: 18678799
J Autism Dev Disord. 2012 Jun;42(6):1236-48
pubmed: 21584849
J Child Psychol Psychiatry. 2014 Aug;55(8):945-53
pubmed: 24552513
Nat Rev Neurosci. 2002 Mar;3(3):201-15
pubmed: 11994752
Cereb Cortex. 2007 Apr;17(4):951-61
pubmed: 16772313
Proc Natl Acad Sci U S A. 2006 May 23;103(21):8275-80
pubmed: 16702548
Biol Psychiatry. 2013 Aug 1;74(3):189-94
pubmed: 23374640
J Autism Dev Disord. 2013 Jun;43(6):1287-97
pubmed: 23065116
Biol Psychiatry. 2011 May 1;69(9):847-56
pubmed: 21195388
J Autism Dev Disord. 2017 Jan;47(1):58-67
pubmed: 27696176
Front Hum Neurosci. 2013 Nov 28;7:814
pubmed: 24348363
Psychol Bull. 2011 Jul;137(4):562-93
pubmed: 21574682
Neuroimage. 2010 Oct 15;53(1):303-17
pubmed: 20600998
Neuron. 2004 Mar 4;41(5):809-23
pubmed: 15003179
Hum Brain Mapp. 2015 Apr;36(4):1348-64
pubmed: 25504834
Proc Natl Acad Sci U S A. 2008 Aug 26;105(34):12569-74
pubmed: 18723676
Neuroscientist. 2017 Apr;23(2):169-184
pubmed: 26929236
Biol Psychiatry. 2016 Apr 15;79(8):633-41
pubmed: 26543004
Behav Brain Funct. 2016 Jan 20;12(1):3
pubmed: 26790724
Sci Rep. 2015 Feb 06;5:8284
pubmed: 25655672
J Child Psychol Psychiatry. 2004 May;45(4):719-26
pubmed: 15056304
J Child Psychol Psychiatry. 2005 Dec;46(12):1255-68
pubmed: 16313426
Curr Biol. 2015 Jun 29;25(13):1727-30
pubmed: 26073135
Neurosci Biobehav Rev. 2008;32(1):123-42
pubmed: 17706781
J Autism Dev Disord. 2015 Apr;45(4):943-52
pubmed: 25261248
Hum Brain Mapp. 2009 Aug;30(8):2313-35
pubmed: 19034900
Brain. 2008 Sep;131(Pt 9):2464-78
pubmed: 18550622
Front Hum Neurosci. 2014 Feb 06;8:34
pubmed: 24567709
Cereb Cortex. 2013 Mar;23(3):594-603
pubmed: 22368080
J Cogn Neurosci. 2013 Jan;25(1):74-86
pubmed: 22905821
Am J Psychiatry. 2010 Nov;167(11):1349-56
pubmed: 20889652
Nature. 2017 Feb 15;542(7641):348-351
pubmed: 28202961
Sci Transl Med. 2017 Jun 7;9(393):
pubmed: 28592562
Neuron. 2008 May 8;58(3):306-24
pubmed: 18466742
Nat Rev Neurosci. 2001 Jul;2(7):475-83
pubmed: 11433372
Arch Neurol. 2007 Jul;64(7):945-50
pubmed: 17620483
J Autism Dev Disord. 2010 Dec;40(12):1521-30
pubmed: 20405194
Brain. 2004 Aug;127(Pt 8):1811-21
pubmed: 15215213
Cereb Cortex. 2015 Dec;25(12):4740-7
pubmed: 25073720
Proc Natl Acad Sci U S A. 2005 Jul 5;102(27):9673-8
pubmed: 15976020
Am J Psychiatry. 2013 Aug;170(8):899-908
pubmed: 23511344
Mol Psychiatry. 2014 Jun;19(6):659-67
pubmed: 23774715
Neuroimage. 2014 Jan 1;84:320-41
pubmed: 23994314
Nature. 2013 Dec 19;504(7480):427-31
pubmed: 24196715
Mol Autism. 2017 Mar 4;8:8
pubmed: 28316772
Dev Cogn Neurosci. 2018 Jan;29:151-167
pubmed: 28545994
Autism Res. 2015 Feb;8(1):38-51
pubmed: 25258047
Nat Neurosci. 2015 Feb;18(2):302-9
pubmed: 25599222
J Neurosci. 2010 Aug 25;30(34):11379-87
pubmed: 20739559
J Autism Dev Disord. 2009 May;39(5):765-74
pubmed: 19148740
Neuron. 2011 Nov 17;72(4):665-78
pubmed: 22099467
Dev Cogn Neurosci. 2015 Apr;12:12-39
pubmed: 25459874
JAMA Psychiatry. 2013 Aug;70(8):869-79
pubmed: 23803651
Neuroimage. 2008 Jan 1;39(1):527-37
pubmed: 17919929
Hum Brain Mapp. 2014 Apr;35(4):1284-96
pubmed: 23334984
Front Hum Neurosci. 2013 Aug 06;7:430
pubmed: 23964221
J Neurophysiol. 2008 Dec;100(6):3328-42
pubmed: 18799601
Autism. 2008 Sep;12(5):457-72
pubmed: 18805942
Am J Psychiatry. 2012 Jun;169(6):589-600
pubmed: 22362397
PLoS One. 2017 Nov 17;12(11):e0188122
pubmed: 29149191
Autism Res. 2017 Jan;10(1):130-143
pubmed: 27205875
J Autism Dev Disord. 2007 May;37(5):855-66
pubmed: 17048092
Neuroimage. 2013 Jan 1;64:240-56
pubmed: 22926292
J Autism Dev Disord. 2000 Jun;30(3):237-43
pubmed: 11055459
Dev Cogn Neurosci. 2015 Apr;12:123-33
pubmed: 25704288
Autism Res. 2010 Apr;3(2):78-87
pubmed: 20437603
Biol Psychiatry. 2007 Aug 1;62(3):198-206
pubmed: 17137558
J Autism Dev Disord. 2009 Jan;39(1):57-66
pubmed: 18566881
Nat Neurosci. 2013 Sep;16(9):1348-55
pubmed: 23892552
Cereb Cortex. 2018 Feb 01;28(2):750-763
pubmed: 29186388
Cereb Cortex. 2010 Dec;20(12):2852-62
pubmed: 20237243
J Neurodev Disord. 2009 Jun;1(2):114-32
pubmed: 21547711
Neuroimage. 2012 Jan 2;59(1):431-8
pubmed: 21810475
Cereb Cortex. 2011 Jan;21(1):145-54
pubmed: 20421249
Neuroimage. 2012 Feb 1;59(3):2142-54
pubmed: 22019881
Cereb Cortex. 2014 Jul;24(7):1894-905
pubmed: 23425893
Dev Psychopathol. 2013 Aug;25(3):773-84
pubmed: 23880391
Neuroreport. 2006 Nov 6;17(16):1687-90
pubmed: 17047454
Brain Res. 2012 Jan 5;1428:60-70
pubmed: 21466793
Cereb Cortex. 2001 Dec;11(12):1110-23
pubmed: 11709482
Autism Res. 2010 Aug;3(4):162-73
pubmed: 20589716
Brain. 2005 May;128(Pt 5):1038-48
pubmed: 15758039

Auteurs

Claire J McKinnon (CJ)

Department of Psychiatry, Washington University School of Medicine, St. Louis, Missouri; Biological Sciences Division, University of Chicago, Chicago, Illinois. Electronic address: cmckinnon@uchicago.edu.

Adam T Eggebrecht (AT)

Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri.

Alexandre Todorov (A)

Department of Psychiatry, Washington University School of Medicine, St. Louis, Missouri.

Jason J Wolff (JJ)

Department of Educational Psychology, University of Minnesota, Minneapolis, Minnesota.

Jed T Elison (JT)

Institute of Child Development, University of Minnesota, Minneapolis, Minnesota.

Chloe M Adams (CM)

Department of Psychiatry, Washington University School of Medicine, St. Louis, Missouri.

Abraham Z Snyder (AZ)

Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri.

Annette M Estes (AM)

Department of Speech and Hearing Sciences, University of Washington, Seattle, Washington.

Lonnie Zwaigenbaum (L)

Department of Pediatrics, University of Alberta, Edmonton, Alberta.

Kelly N Botteron (KN)

Department of Psychiatry, Washington University School of Medicine, St. Louis, Missouri; Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri.

Robert C McKinstry (RC)

Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri.

Natasha Marrus (N)

Department of Psychiatry, Washington University School of Medicine, St. Louis, Missouri.

Alan Evans (A)

McConnell Brain Imaging Center, Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada.

Heather C Hazlett (HC)

The Carolina Institute for Developmental Disabilities, University of North Carolina at Chapel Hill, Carborro, North Carolina.

Stephen R Dager (SR)

Department of Radiology and Bioengineering, University of Washington, Seattle, Washington.

Sarah J Paterson (SJ)

Department of Psychology, Temple University, Philadelphia, Pennsylvania.

Juhi Pandey (J)

Center for Autism Research, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania; Department of Psychiatry, University of Pennsylvania, Philadelphia, Pennsylvania.

Robert T Schultz (RT)

Center for Autism Research, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania; Department of Psychiatry, University of Pennsylvania, Philadelphia, Pennsylvania.

Martin A Styner (MA)

The Carolina Institute for Developmental Disabilities, University of North Carolina at Chapel Hill, Carborro, North Carolina.

Guido Gerig (G)

Tandon School of Engineering, New York University, Brooklyn, New York.

Bradley L Schlaggar (BL)

Department of Psychiatry, Washington University School of Medicine, St. Louis, Missouri; Department of Neurology, Washington University School of Medicine, St. Louis, Missouri; Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri.

Steven E Petersen (SE)

Department of Neurology, Washington University School of Medicine, St. Louis, Missouri; Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri; Department of Psychological and Brain Sciences, Washington University in St. Louis, St. Louis, Missouri; Department of Biomedical Engineering, Washington University in St. Louis, St. Louis, Missouri.

Joseph Piven (J)

The Carolina Institute for Developmental Disabilities, University of North Carolina at Chapel Hill, Carborro, North Carolina.

John R Pruett (JR)

Department of Psychiatry, Washington University School of Medicine, St. Louis, Missouri.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH